Marc Wilson - Dec 31, 2022 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
CFO
Signature
/s/ Marc Wilson
Stock symbol
CRNX
Transactions as of
Dec 31, 2022
Transactions value $
$21,247
Form type
5
Date filed
1/27/2023, 03:29 PM
Previous filing
Mar 2, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $15.9K +1.45K +1.77% $11.02 83.1K May 20, 2022 Direct F1
transaction CRNX Common Stock Other $5.31K +482 +0.58% $11.02 83.5K Nov 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),